Role of metabolic syndrome components in HIV-associated sensory neuropathy
暂无分享,去创建一个
F. Vaida | I. Grant | B. Ances | D. Clifford | R. Ellis | J. McCutchan | D. Simpson | J. McArthur | D. Rosario | J. Marquie‐Beck | Debralee Rosario
[1] I. Grant,et al. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy , 2008, Annals of neurology.
[2] D. Simpson,et al. Diagnosis and management of HIV-associated neuropathy. , 2008, Neurologic clinics.
[3] F. Rodríguez‐Artalejo,et al. Effectiveness of Blood Pressure Control Outside the Medical Setting , 2007, Hypertension.
[4] D. Clifford,et al. HIV neuropathy natural history cohort study , 2006, Neurology.
[5] X. Pi-Sunyer,et al. The metabolic syndrome: how to approach differing definitions. , 2007, The Medical clinics of North America.
[6] S. Azar,et al. Hypertriglyceridemia and peripheral neuropathy in neurologically asymptomatic patients. , 2005, Neuro endocrinology letters.
[7] R. Krauss,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.
[8] H. Sone,et al. Vascular risk factors and diabetic neuropathy. , 2005, The New England journal of medicine.
[9] Daniel W. Jones,et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.
[10] D. Simpson,et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. , 2004, Archives of neurology.
[11] J. Gross,et al. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[12] K. Marder,et al. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy , 2002, Neurology.
[13] C. Autore,et al. Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents. , 2002, Italian heart journal : official journal of the Italian Federation of Cardiology.
[14] L. Groop,et al. The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes , 2001, Diabetologia.
[15] D. Cooper,et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study , 1999, The Lancet.
[16] B. Swanson,et al. HIV-associated distal symmetrical polyneuropathy: clinical features and nursing management. , 1998, The Journal of the Association of Nurses in AIDS Care : JANAC.
[17] J. Becker,et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. , 1994, Neurology.
[18] M. Górgolas Hernández-Mora,et al. [Clinical and subclinical neuropathy in patients with human immunodeficiency virus receiving antiretroviral therapy]. , 2006, Revista de neurologia.
[19] S. Dorsey,et al. HIV peripheral neuropathy: pathophysiology and clinical implications. , 2006, AACN clinical issues.
[20] K. Lichtenstein,et al. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] J. McArthur,et al. Recent developments in the HIV neuropathies. , 2003, Current opinion in neurology.
[22] M. Tagliati,et al. Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. , 1999, Archives of neurology.